Starkey Announces Launch of ‘Listen Carefully’ Advocacy Initiative
EDEN PRAIRIE, MINNESOTA – Starkey has announced the launch of Listen Carefully, a new initiative aimed at “bridging the conversation between hearing healthcare providers and lawmakers in Washington, D.C.” The effort follows President Joe Biden’s recent executive order that calls on the Department of Health and Human Services to consider issuing proposed rules for hearing…
Read More
World Health Organization Launches Guide for Hearing Screening Programs
The first ever World report on hearing was launched in 2021, as a technical guide outlining the ongoing shifts in the global epidemiology of hearing loss, capturing available solutions and current challenges for ear and hearing care and also establishing priorities to be addressed. It highlights the link between addressing hearing loss and achieving the Sustainable Development Goals. The rationale for hearing screening across the life course is well outlined…
Read More
Plural Publishing Announces Release of ‘Clinical Audiology: An Introduction,’ Third Edition Textbook
SAN DIEGO, CALIFORNIA – Plural Publishing announces the release of the third edition of Clinical Audiology: An Introduction. The updated text provides a comprehensive enhancement of all the introductory material available in previous editions. Students can gain an understanding of the scope of the field of audiology and feel prepared to dive deeper into the…
Read More
Starkey Hosts U.S. Senator Amy Klobuchar at Global Headquarters
EDEN PRAIRIE, MINNESOTA – Starkey welcomed U.S. Senator Amy Klobuchar of Minnesota to its global corporate headquarters last week. During the visit, Senator Klobuchar toured Starkey’s technology center and manufacturing facilities. She was also debriefed on the company’s newest technology, Evolv AI hearing aids, which was released by Starkey earlier this month. Klobuchar’s visit comes…
Read More
Oticon Announces Call for Nominations for the 2021 Focus on People Awards
SOMERSET, NEW JERSEY –– Oticon, Inc. is looking for outstanding people with hearing loss for the 2021 Oticon Focus on People Awards. Nominations are now open for the national awards program that honors students, adults and advocacy volunteers with any degree of hearing loss whose accomplishments show that hearing loss does not limit a person’s…
Read More
Sensorion and Sonova Sign Strategic Research Collaboration
MONTPELLIER, FRANCE — Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN), a pioneering clinical-stage biotech company specializing in the development of novel therapies to restore, treat, and prevent hearing related disorders, and hearing-care industry leader Sonova (SWX:SOON), have signed a multi-year strategic collaboration with the aim of introducing genetic analysis to the routine diagnosis of progressive hearing loss in adults,…
Read More
Neuromod Names Eric Timm as CEO of US Division
DUBLIN, IRELAND — Neuromod Devices Ltd, the medical device company specializing in neuromodulation technologies, has announced the appointment of Mr. Eric Timm as Chief Executive Officer of its recently established US entity, Neuromod USA Inc., effective from 1st October 2021. Mr. Timm’s appointment to lead the U.S. business comes as Neuromod prepares to enter the…
Read More
Decibel Therapeutics Gene Therapy Hearing Loss Treatment, DB-OTO, Receives Orphan Drug and Rare Pediatric Disease Designations from FDA
BOSTON, MASSACHUSSETTS — Decibel Therapeutics, a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation and Rare Pediatric Disease Designation for the company’s lead gene therapy product candidate, DB-OTO, for the…
Read More
Sensorion and Cochlear to Begin Trial of SENS-401 for Hearing Preservation in Combination With Cochlear Implantation
MONTPELLIER, FRANCE & SYDNEY, AUSTRALIA — Sensorion, a pioneering clinical-stage biotechnology startup specializing in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, and Cochlear Limited, the global leader in implantable hearing solutions, announce the initiation of a pilot study of the first-in-class small molecule drug SENS-401…
Read More
Younger Children More Likely to Experience Hearing Loss from Chemo Drug, Cisplatin
According to a new study by researchers at the University of British Columbia (UBC), a chemotherapy drug known to cause hearing loss in children is more likely to do so the earlier in life children receive it. Cisplatin is a life-saving treatment for many children with cancer, but the study published today in Cancer shows that the hearing of…
Read More